This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by SPEISER, P. W. Articles by NEW, M. I. Search for Related Content PubMed PubMed Citation Articles by SPEISER, P. W. Articles by NEW, M. I.

Genotype and Hormonal Phenotype in Nonclassical 21-Hydroxylase Deficiency^*

Division of Pediatric Endocrinology, The New York Hospital-Cornell Medical Center New York, New York 10021

Address requests for reprints to: Dr. Phyllis Speiser, Division of Pediatric Endocrinology, The New York Hospital-Cornell Medical Center, 525 East 68th Street, New York, New York 10021.

In nonclassical steroid 21-hydroxylase deficiency, the genotype may be represented as a homozygous mild (nonclassicai) form of the 21-hydroxylase defect or as a compound heterozygote, with one severe (classical) and one mild (nonclassical) 21-hydroxylase deficiency allele. We examined hormone levels in patients with nonclassical 21-hydroxylase deficiency in whom pedigree analysis and/or HLA linkage disequilibrium allowed unequivocal identification of the respective haplotypes as either classical or nonclassical. The results indicated that compound heterozygotes (21-OH def^severe/21-OH def^mild) have an ACTH-stimulated 17-hydroxyprogesterone (17-OHP) response significantly greater than that of mild homozy-gotes (21-OH der^mild/21-OH def^mild): at 60 min, 8,131 ± 4,205 (± SD) (n = 17) vs. 4,468 ± 2,123 ng/dl (n = 31) for the respective groups (P < 0.01); at 360 min, 11,067 ± 5,582 (n = 17) vs. 5746 ± 1565 (n = 8, P < 0.01). Since serum cortisol levels were the same in both groups, the ratio of 17-OHP to cortisol was higher in the former group. Sixty minute ACTH-stimulated serum ⁴-androstenedione levels also were significantly higher in compound heterozygotes than in mild homozygotes. Serum dehydro-epiandrosterone and its sulfate were not signicantly different between the two groups. Notably, compound heterozygotes were no more likely to have signs of androgen excess than were homozygotes for the mild gene defect.

Stimulated levels of serum 17-OHP, 17-OHP/cortisol, ⁴-androstenedione and dehydroepiandrosterone and its sulfate did not differ significantly between heterozygotes for the classical (21-OH def^severe/21-OH^normal) and nonclassical (21-OH def^mild/21-OH^normal) 21-hydroxylas e deficiency alleles. Thus, the presence of a single normal 21-hydroxylase allele is sufficient to obscure the difference between a severe and a mild 21-hydroxy-lase deficiency allele on the opposite haplotype.

We conclude that the compound heterozygous patients as a group have a significantly higher response of 21-hydroxylase precursors to ACTH stimulation than do patients with the homozygous mild 21-hydroxylase deficiency state.

^* This work was supported by USPHS NIH Grants HD-00072 and AM-07029 and Division of Research Resources (NIH) Grants SO7 RR-05396 (BRSG Program) and RR-00047 (GCRC Program). Aid is also acknowledged from the Horace Goldsmith Foundation. Presented in part at the 56th Annual Meeting of the Society for Pediatric Research, Washington DC, May, 1986.

Received May 27, 1986.

This article has been cited by other articles:

				R. Menassa, V. Tardy, F. Despert, C. Bouvattier-Morel, J. P. Brossier, M. Cartigny, and Y. Morel p.H62L, a Rare Mutation of the CYP21 Gene Identified in Two Forms of 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1901 - 1908. [Abstract] [Full Text] [PDF]

				A. T. Soliman, M. Omar, M. Al Ali, M. M. Rizk, I. Nasr, and M. AbolMagd Congenital Adrenal Hyperplasia: Family Screening Using 17-hydroxyprogesterone (17-OHP) Response to Adrenocorticotopin (ACTH) J Trop Pediatr, April 1, 2006; 52(2): 147 - 148. [Full Text] [PDF]

				P. W. Speiser and P. C. White Congenital Adrenal Hyperplasia N. Engl. J. Med., August 21, 2003; 349(8): 776 - 788. [Full Text] [PDF]

				P. C. White and P. W. Speiser Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency Endocr. Rev., June 1, 2000; 21(3): 245 - 291. [Abstract] [Full Text]

				T. Tajima, K. F. Jun Nakae, T. Toyoura, K. Shimozawa, S. Kusuda, K. Goji, T. Nagashima, and G. B. Cutler Jr. Molecular Basis of Nonclassical Steroid 21-Hydroxylase Deficiency Detected by Neonatal Mass Screening in Japan J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2350 - 2356. [Abstract] [Full Text] [PDF]